Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Liquid vs Solid Formulations of Pudafensine (IP2015) in Healthy Men
NCT05728671Phase 1Unknown
- Sponsor
- Initiator Pharma A/S
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of pudafensine in erectile dysfunction (ED) and neuropathic pain (3 arms), sponsored by Initiator Pharma A/S. Primary endpoints: Area Under the Curve at 72 hours, Time to Maximum Concentration at 72 hours and 1 more. Status: unknown.
02
Drugs
pudafensine
03
Conditions
erectile dysfunction (ED)neuropathic pain
Beyond the preview
Go deeper on NCT05728671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728671.